more pruning
Just unload my position in BMY. I entered into both MRK and BMY at the same time last year as I was being bearish on the market. Both stock looked cheap to me. The 5~6% yield on both are excellent hedge again a down market. I believed the market was over reacting to the expiration of drug companies' patents. Observe that people are still buying Tynenol, even though every pharmacy store and big grocery chains has their generic version Acetaminaphen. At the time, the three big drug companies, MRK, BMY, PFE all looked cheap. I ultimately went with MRK, which I still hold, and BMY. MRK was clearly oversold, and I got in the bottom. As for BMY, I am starting to have doubts about its management's capability. The move is more influenced by my thoughts after reading the book Good To Great. I simply can not envision BMY can be a Great company at this point. Ironically, I thought PFE had the biggest risk at the time, but it has out-performed BMY by a wide margin so far. I unload BMY also because after I examined my portfolio, I came away with the conclusion that I have a little more exposure in pharmaceutical area than I would like. It was the same reason why I sold my NUTR shares yesterday.
BMY was 4% of my portfolio.

